Logo image of TRNR

INTERACTIVE STRENGTH INC (TRNR) Stock Fundamental Analysis

NASDAQ:TRNR - Nasdaq - US45840Y3027 - Common Stock - Currency: USD

0.9125  -0.1 (-9.65%)

After market: 0.9201 +0.01 (+0.83%)

Fundamental Rating

1

TRNR gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 30 industry peers in the Leisure Products industry. Both the profitability and financial health of TRNR have multiple concerns. TRNR has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year TRNR has reported negative net income.
In the past year TRNR has reported a negative cash flow from operations.
TRNR had negative earnings in each of the past 5 years.
TRNR had a negative operating cash flow in each of the past 5 years.
TRNR Yearly Net Income VS EBIT VS OCF VS FCFTRNR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -10M -20M -30M -40M -50M

1.2 Ratios

TRNR's Return On Assets of -102.24% is on the low side compared to the rest of the industry. TRNR is outperformed by 93.33% of its industry peers.
TRNR has a worse Return On Equity (-490.99%) than 90.00% of its industry peers.
Industry RankSector Rank
ROA -102.24%
ROE -490.99%
ROIC N/A
ROA(3y)-215.39%
ROA(5y)-197.2%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TRNR Yearly ROA, ROE, ROICTRNR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 1K -1K 2K -2K

1.3 Margins

TRNR does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
TRNR Yearly Profit, Operating, Gross MarginsTRNR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 -2K -4K -6K -8K -10K

0

2. Health

2.1 Basic Checks

TRNR does not have a ROIC to compare to the WACC, probably because it is not profitable.
TRNR has more shares outstanding than it did 1 year ago.
The debt/assets ratio for TRNR has been reduced compared to a year ago.
TRNR Yearly Shares OutstandingTRNR Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 5M 10M
TRNR Yearly Total Debt VS Total AssetsTRNR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

Based on the Altman-Z score of -11.43, we must say that TRNR is in the distress zone and has some risk of bankruptcy.
TRNR has a worse Altman-Z score (-11.43) than 96.67% of its industry peers.
TRNR has a Debt/Equity ratio of 1.59. This is a high value indicating a heavy dependency on external financing.
TRNR has a worse Debt to Equity ratio (1.59) than 83.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.59
Debt/FCF N/A
Altman-Z -11.43
ROIC/WACCN/A
WACC12.23%
TRNR Yearly LT Debt VS Equity VS FCFTRNR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 -20M -40M

2.3 Liquidity

TRNR has a Current Ratio of 0.31. This is a bad value and indicates that TRNR is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.31, TRNR is not doing good in the industry: 93.33% of the companies in the same industry are doing better.
TRNR has a Quick Ratio of 0.31. This is a bad value and indicates that TRNR is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.16, TRNR is doing worse than 93.33% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.31
Quick Ratio 0.16
TRNR Yearly Current Assets VS Current LiabilitesTRNR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

3

3. Growth

3.1 Past

TRNR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -41.43%.
The Revenue has grown by 459.36% in the past year. This is a very strong growth!
TRNR shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 155.38% yearly.
EPS 1Y (TTM)-41.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.78%
Revenue 1Y (TTM)459.36%
Revenue growth 3Y155.38%
Revenue growth 5YN/A
Sales Q2Q%1202.19%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y14.29%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year54.84%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
TRNR Yearly Revenue VS EstimatesTRNR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 5M 10M 15M 20M
TRNR Yearly EPS VS EstimatesTRNR Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 -200 -400 -600 -800 -1K

0

4. Valuation

4.1 Price/Earnings Ratio

TRNR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year TRNR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TRNR Price Earnings VS Forward Price EarningsTRNR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TRNR Per share dataTRNR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1K -2K -3K -4K

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

TRNR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

INTERACTIVE STRENGTH INC

NASDAQ:TRNR (5/20/2025, 8:00:01 PM)

After market: 0.9201 +0.01 (+0.83%)

0.9125

-0.1 (-9.65%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryLeisure Products
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.92%
Inst Owner Change925.37%
Ins Owners0.01%
Ins Owner Change0%
Market Cap7.48M
Analysts82.86
Price TargetN/A
Short Float %7.98%
Short Ratio0.11
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.39
P/FCF N/A
P/OCF N/A
P/B 1.05
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-4588.24
EYN/A
EPS(NY)-4.9
Fwd EYN/A
FCF(TTM)-1.83
FCFYN/A
OCF(TTM)-1.81
OCFYN/A
SpS0.66
BVpS0.87
TBVpS-1.49
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -102.24%
ROE -490.99%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-215.39%
ROA(5y)-197.2%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.16
Health
Industry RankSector Rank
Debt/Equity 1.59
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 3.46%
Cap/Sales 3.94%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.31
Quick Ratio 0.16
Altman-Z -11.43
F-Score6
WACC12.23%
ROIC/WACCN/A
Cap/Depr(3y)49.7%
Cap/Depr(5y)625.55%
Cap/Sales(3y)422.9%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-41.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.78%
EPS Next Y14.29%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)459.36%
Revenue growth 3Y155.38%
Revenue growth 5YN/A
Sales Q2Q%1202.19%
Revenue Next Year54.84%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y46.43%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year95.65%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y10.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y3.99%
OCF growth 3YN/A
OCF growth 5YN/A